» Articles » PMID: 14532319

Safety of Patients Isolated for Infection Control

Overview
Journal JAMA
Specialty General Medicine
Date 2003 Oct 9
PMID 14532319
Citations 149
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors.

Objective: To examine the quality of medical care received by patients isolated for infection control.

Design, Setting, And Patients: We identified consecutive adults who were isolated for methicillin-resistant Staphylococcus aureus colonization or infection at 2 large North American teaching hospitals: a general cohort (patients admitted with all diagnoses between January 1, 1999, and January 1, 2000; n = 78); and a disease-specific cohort (patients admitted with a diagnosis of congestive heart failure between January 1, 1999, and July 1, 2002; n = 72). Two matched controls were selected for each isolated patient (n = 156 general cohort controls and n = 144 disease-specific cohort controls).

Main Outcome Measures: Quality-of-care measures encompassing processes, outcomes, and satisfaction. Adjustments for study cohort and patient demographic, hospital, and clinical characteristics were conducted using multivariable regression.

Results: Isolated and control patients generally had similar baseline characteristics; however, isolated patients were twice as likely as control patients to experience adverse events during their hospitalization (31 vs 15 adverse events per 1000 days; P<.001). This difference in adverse events reflected preventable events (20 vs 3 adverse events per 1000 days; P<.001) as opposed to nonpreventable events (11 vs 12 adverse events per 1000 days; P =.98). Isolated patients were also more likely to formally complain to the hospital about their care than control patients (8% vs 1%; P<.001), to have their vital signs not recorded as ordered (51% vs 31%; P<.001), and more likely to have days with no physician progress note (26% vs 13%; P<.001). No differences in hospital mortality were observed for the 2 groups (17% vs 10%; P =.16).

Conclusion: Compared with controls, patients isolated for infection control precautions experience more preventable adverse events, express greater dissatisfaction with their treatment, and have less documented care.

Citing Articles

Greening Infection Prevention and Control: Multifaceted Approaches to a Sustainable Future.

Lee P, Frantzis I, Abeles S Open Forum Infect Dis. 2025; 12(2):ofae371.

PMID: 39958523 PMC: 11825990. DOI: 10.1093/ofid/ofae371.


Is there an association between colonisation of vancomycin resistant , methicillin resistant , or and mortality in sepsis?.

Sigakis M, Posluszny J, Maile M, Jewell E, Engoren M Infect Prev Pract. 2024; 6(4):100413.

PMID: 39624778 PMC: 11609449. DOI: 10.1016/j.infpip.2024.100413.


Contact precautions for MRSA and VRE: where are we now? A survey of the Research Network.

Martin E, Morgan D, Pryor R, Bearman G Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e137.

PMID: 39346664 PMC: 11428003. DOI: 10.1017/ash.2024.350.


Patient Experiences and Perceptions with Infections Due to Multidrug-Resistant Organisms: A Systematic Review.

AlRawashdeh M, Ishak A, Al-Bunnia A, Agouridis A, Lytras T, Spernovasilis N Pathogens. 2024; 13(9).

PMID: 39339008 PMC: 11435282. DOI: 10.3390/pathogens13090817.


Doff Thy Gown-Shedding Contact Precautions for COVID-19.

Rabin A, Marr L, Blumberg H Clin Infect Dis. 2024; 79(3):585-587.

PMID: 38747695 PMC: 11426274. DOI: 10.1093/cid/ciae276.